Oncology Institute, Inc.
Extracted from this filing and checked against the source text.
Oncology Institute, Inc. shareholders approved Election of nine directors at the 2023-06-15 meeting.
Proposal 1: Election of Directors All nine nominated directors were elected to hold office until the Company's 2024 annual meeting of stockholders. The stockholders voted as follows: Nominee Votes For Votes Against Votes Withheld Broker Non-Votes Brad Hively 53,352,627 — 961,581 10,682,415 Richard Barasch 53,577,014 — 737,194 10,682,415 Karen Johnson 53,236,553 — 1,077,655 10,682,415 Mohit Kaushal 41,300,185 — 13,014,023 10,682,415 Anne McGeorge 40,469,060 — 13,845,148 10,682,415 Maeve O’Meara 52,748,849 — 1,565,359 10,682,415 Ravi Sarin 40,412,516 — 13,901,692 10,682,415 Gabriel Ling 53,854,419 — 459,789 10,682,415 Mark Pacala 54,230,930 — 83,278 10,682,415View on SEC.gov
Oncology Institute, Inc. shareholders approved Ratification of the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-15 meeting.
Proposal 2: Ratification of the Appointment of Independent Registered Public Accountants The ratification of the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023, the stockholders voted as follows: Votes For Votes Against Abstentions Broker Non-Votes 64,306,320 444,591 245,712 —View on SEC.gov
461 shareholder votes filed in the last 30 days. Browse all shareholder votes →
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.